Nektar Therapeutics is a leading biopharma company headquartered in San Francisco. The company is listed in the top 50 big biotech list by Current Partnering. The company is a world leader in polymer chemistry which involves the design of drugs with optimized drug pharmacology. Read the full story

Carl Icahn, the billionaire investor who has targeted at least seven drug companies in the past five years, threatened a proxy fight at biotech company Amylin Pharmaceuticals Inc. and urged the drugmaker to pursue a sale Read the full story